
Metofin ER 25 Tablet
Marketer
Q Check Speciality Care
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Metofin ER 25 Tablet
Extended-release Metofin 25mg tablets are beta-blockers used to manage hypertension, angina pectoris, and cardiac arrhythmias. They also help prevent migraines, recurrent heart attacks, and strokes. Prescribed individually or in combination with other drugs, dosage varies depending on the treated condition and its severity. Administer consistently at the same time daily, with or without food, for optimal effectiveness. Full therapeutic benefit may take weeks to manifest, and continuous use might be necessary. Discontinuation may exacerbate underlying conditions, as hypertension often presents asymptomatically. Common, generally mild and transient, adverse effects include fatigue, cephalgia, depressive symptoms, diarrhea, skin rashes, bradycardia, lightheadedness, and nausea. Less frequently, shortness of breath or hypotension may occur. Gradual dose escalation minimizes adverse reactions. Report persistent or bothersome side effects to your physician. Prior to initiation, disclose any hepatic impairment. Contraindications include pre-existing bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Consult your doctor before use during pregnancy or breastfeeding. Individual suitability must be determined by your physician, and regular blood pressure monitoring is essential to gauge treatment efficacy. Alcohol consumption should be limited due to the potential for increased side effects.
Primary Ingredients of Metofin ER 25 Tablet
The provided text is "undefined," so no rephrasing is possible.
Uses of Metofin ER 25 Tablet
Managing angina pectoris (chest pain due to heart issues) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Controlling hypertension (high blood pressure) | Preventing migraine headaches
Major Benefits of Metofin ER 25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Metofin ER 25 Tablet whole; do not chew, crush, or break it. This medication can be taken with or without food, but consistent timing is recommended. For optimal absorption, avoid consuming Metofin ER 25 Tablet with meals high in fat, including foods like olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and red meat.
Common Side effects of Metofin ER 25 Tablet:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metofin ER 25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metofin ER 25 Tablet whole; do not crush, chew, or divide it. This medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat, while taking Metofin ER 25 Tablets.
How Metofin ER 25 Tablet works:
Extended-release metoprolol succinate (25 mg) tablets are a cardioselective beta-adrenergic blocking agent. This medication reduces heart rate and improves the heart's pumping efficiency, thereby enhancing circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Metofin ER 25 Tablet is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release metofin 25 mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Extended-release metoformin 25 mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release metoprolol succinate 25 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if you experience these effects.
KidneySAFE IF PRESCRIBED
Extended-release metoformin 25 mg tablets are considered safe for use in individuals with kidney impairment. No alteration of the metoformin 25 mg extended-release tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Metofin ER 25 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Metofin ER 25 Tablet :
Should you forget a Metofin ER 25 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Metofin ER 25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
